Evolution of an ex vivo lentiviral vector manufacturing platform for in vivo applications
Conference Dates
February 1 – 5, 2026
Abstract
Please click Additional Files below to see the full abstract
Recommended Citation
Neil Blackburn, "Evolution of an ex vivo lentiviral vector manufacturing platform for in vivo applications" in "Advancing Manufacture of Cell and Gene Therapies IX [2026]", John Moscariello, Neuvogen, USA Corinne Hoesli, McGill University, Canada Bruno Marques, Century Therapeutics, USA Eds, ECI Symposium Series, (2026). https://dc.engconfintl.org/cell_gene_therapies_ix/84
76.pdf (88 kB)
COinS